You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) EDETATE CALCIUM DISODIUM


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing EDETATE CALCIUM DISODIUM excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing EDETATE CALCIUM DISODIUM excipient

Market Dynamics and Financial Trajectory for the Pharmaceutical Excipient: EDTA Disodium Calcium Salt

Last updated: January 15, 2026

Summary

Ethylenediaminetetraacetic acid disodium calcium salt (EDTA disodium calcium salt) is a chelating agent extensively used in pharmaceuticals, food, and industrial applications. Its role as an excipient stabilizer, chelating agent, and preservative enhancer positions it as a crucial commodity within the specialty chemical and pharmaceutical landscapes. This analysis explores the current market dynamics, growth drivers, challenges, and financial projections for EDTA disodium calcium salt, emphasizing how regulatory frameworks, technological innovations, and demand in end-use sectors will shape future trends.


What is EDTA Disodium Calcium Salt?

Chemical Profile & Uses

Parameter Description
Chemical formula C10H12CaN2Na4O8·4H2O
CAS number 13446-86-9
Key functions Chelation of metal ions, stabilization of pharmaceuticals, food preservation, industrial water treatment
Main industries Pharmaceuticals (as an excipient), food industry (as a preservative), textiles, water treatment

Pharmaceutical Applications

Primarily, EDTA disodium calcium salt serves as a stabilizer, preventing metal-catalyzed oxidation in drugs. Notable formulations include parenteral products and cardiac medications. It also acts as an excipient to enhance the shelf-life of injectable solutions and oral drugs, owing to its chelating properties that inhibit metal ion-induced degradation.


Market Dynamics: Current Landscape and Growth Drivers

Global Market Size and Forecast

Year Estimated Market Size (USD billion) Compound Annual Growth Rate (CAGR) Source / Notes
2022 $250 million - Estimated based on recent industry reports
2023 $262 million 5.0% Estimated projection
2027 $339 million 7.0% Expected driven by expanding pharmaceutical applications

Note: All figures are estimates derived from industry analyses such as Grand View Research and Research and Markets.

Growth Drivers

Driver Impact Details
Expanding pharmaceutical sector High Increasing demand for stabilizers and excipients in injectable and oral medications
Growing geriatric population High Age-related diseases drive demand for complex, longer shelf-life drugs
Rising awareness of drug stability Moderate Regulatory requirements push for advanced excipients
Food preservation regulations Moderate Food industry drives demand for EDTA derivatives as preservatives
Industrial water treatment growth Low Alternative chelating agents gaining ground

Regulatory Environment

Regulatory frameworks significantly influence EDTA disodium calcium salt's market trajectory:

  • United States: Approved by the FDA as a food additive and pharmaceutical excipient.
  • European Union: Listed under E404i (calcium disodium EDTA) permitted in foods and medicinal products.
  • India & China: Subject to national standards aligned with ISO and FAO/WHO guidelines.

Stringent regulatory approval processes can delay market entry but also create high entry barriers, minimizing competition in certain regions.

Supply Chain & Manufacturing

Key manufacturing regions include China, India, and Europe, with China's production accounting for approximately 45-50% of global output (per sources [1], [2]). Major players include Dow Chemical, BASF, and regional producers.

Supply chain disruptions—such as raw material shortages or geopolitical tensions—can impact market availability and pricing.

End-Use Market Segments & Regional Demand

Segment Major Regions Key Trends Market Share (2023)
Pharmaceuticals North America, Europe, Asia-Pacific 60% 60%
Food Industry Europe, North America, Asia-Pacific 25% 25%
Industrial & Water Treatment Global 15% 15%

Financial Trajectory: Key Trends and Projections

Revenue Streams and Pricing

Parameter Recent Data Notes
Average price (USD/kg) $8 - $10 Prices are volatile, influenced by raw material costs and demand-supply dynamics
Revenue growth 4-6% annually Driven by demand in pharmaceutical and food sectors

Cost Structure & Margins

Cost Element Typical Percentage Remarks
Raw materials 50-60% Mainly calcium salts, amino acids, and chemicals
Manufacturing 15-20% Energy, labor, process management
Regulatory & compliance 10% Certification, quality assurance
Distribution & sales 10-15% Logistics, marketing

Profitability & Investment Outlook

With stable demand and moderate price fluctuations, profit margins for established manufacturers average 15-20%. Margins can exceed 25% in regions with high-value pharmaceutical-grade product sales.

Financial Risks and Challenges

  • Raw material price volatility
  • Stringent regulatory approvals delaying revenue realization
  • Competition from synthetic and natural chelating agents

Market Comparisons: EDTA Disodium Calcium Salt vs. Alternatives

Aspect EDTA Disodium Calcium Salt Alternative Agents
Metal chelation efficiency High EDTA Tetrasodium, DTPA
Regulatory approval Widely approved Varies by region
Cost Moderate Similar to higher-end options
Stability Excellent Comparable

The choice hinges on application-specific requirements, regulatory status, and cost considerations.


Future Outlook & Trends

Innovation and R&D Focus Areas

  • Development of biodegradable and eco-friendly chelants to align with sustainability mandates.
  • Enhanced pharmaceutical-grade purity standards to expand use in sterile formulations.
  • Novel formulations integrating EDTA salts for targeted delivery.

Potential Market Barriers

  • Evolution of alternative chelants with improved safety profiles.
  • Regulatory bans in specific regions due to toxicity concerns.
  • Price sensitivity in food-grade applications.

Impact of Manufacturing Consolidation

Consolidation among key producers could lead to increased pricing power and stabilized supply chains, fostering steady revenue streams.


Conclusion

The EDTA disodium calcium salt market exhibits steady growth, primarily propelled by expanding pharmaceutical applications and regulatory evolution favoring its use as an excipient. While regional disparities and raw material costs pose challenges, technological advances and industry consolidation hint at a resilient outlook over the next five years, with an expected CAGR of approximately 6-7%. Companies deploying strategic R&D, supply chain robustness, and compliance agility will position themselves favorably in this landscape.


Key Takeaways

  • The global EDTA disodium calcium salt market is projected to grow at a CAGR of approximately 6-7% from 2023 to 2027.
  • Pharmaceutical applications, especially as a stabilizer and excipient, dominate demand, accounting for about 60% of total usage.
  • Price fluctuations are influenced by raw material costs, regional regulations, and competitive dynamics.
  • Regional markets differ significantly, with China leading global production and North America and Europe being high-value consumers.
  • Regulatory compliance and technological innovation are critical to gaining market access and maintaining competitive advantage.

FAQs

1. What are the main factors driving the demand for EDTA disodium calcium salt?

The primary drivers include increased pharmaceutical formulations requiring stabilization, food preservation standards, aging populations demanding complex medications, and rising awareness of drug stability and shelf-life extension.

2. How do regulatory policies impact the market for EDTA disodium calcium salt?

Regulatory approvals, such as those from the FDA and EFSA, facilitate global market access but also impose compliance costs. Stringent standards can inhibit entry for new players, while relaxed policies can lead to increased competition.

3. What are the chief challenges facing manufacturers of EDTA disodium calcium salt?

Challenges include raw material price volatility, regulatory hurdles, environmental concerns related to manufacturing processes, and competition from natural or synthetic chelants with superior safety profiles.

4. How does regional production influence global supply and pricing?

China’s dominance in production (approximately 45-50%) affects global supply dynamics, with regional policies and trade tensions impacting pricing and availability.

5. What innovations could reshape the EDTA disodium calcium salt market?

Advancements include biodegradable chelants, purification processes enhancing pharmaceutical-grade quality, and formulations that improve safety profiles, potentially expanding application scope.


References

[1] Research and Markets. “Global EDTA Market Analysis,” 2022.
[2] Grand View Research. “Chemical Chelates Market Report,” 2021.
[3] U.S. Food and Drug Administration. “Regulatory Status of EDTA,” 2022.
[4] European Food Safety Authority. “Approval of EDTA in Food Applications,” 2022.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.